Search results for: England
Filter search results
Routine Funding in the UK NHS of Medicines Authorised Between 2011 and 2016 via the European Centralised Procedure
18 December 2017
…the period of interest this includes 61 products directly funded by NHS England specialised commissioning. We identified 25 orphan medicinal products that were directly commissioned by NHS England. Additionally despite…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
20 March 2019
…between health outcomes and health expenditures in England. Results suggest that setting a cost-effectiveness criterion for NICE may not be capable of being synthesised using scientific methods alone, but involve…
Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
1 March 2019
…between health outcomes and health expenditures in England. Results suggest that setting a cost-effectiveness criterion for NICE may not be capable of being synthesised using scientific methods alone, but involve…
NICE at 25: Technology Appraisals – Faster Access to Modern Treatment?
1 May 2024
…categories enhanced NICE HTA methodology, formalising the principle of funding with evidence collection. NICE and NHS England Further reorganisation of the NHS in 2011 saw the creation of NHS England….
Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics
16 January 2024
…for 10 years, which may not be sufficient to constitute England’s fair share (see Brassel et al., 2023) of a global pull incentive. Following the pilot, NHS England published proposals for a new scheme…
Do Financial Incentives Trump Clinical Guidance? Hip Replacement in England and Scotland
28 April 2015, 11:00pm
… Following devolution in 1999 England and Scotland’s National Health Systems (NHS) diverged, resulting in major differences in hospital payment policies. England introduced a case based payment mechanism from 2003/4,…
Can we “Netflix” the Broken Antibiotics Market?
28 September 2022, 3:00pm
…NHS England to develop and test innovative models for the evaluation and purchase of antimicrobials. David Glover, Deputy Head of the Medicines Analysis Team at NHS England and Improvement David…
OHE Awarded £457K Grant on Measuring Public Preferences for Health States
2 August 2012
…Institute for Health Research (NIHR) for research to produce an EQ-5D-5L Value Set for England. Prof Nancy Devlin OHE’s Prof Nancy Devlin and Prof Ben van Hout of the…
OHE and ABPI Webinar: New EQ-5D-5L value sets for England and the UK and Implications for HTA
11 July 2016
…for England and the UK and implications for HTA. The EQ-5D is one of the most widely used generic measures of health related quality of life (HRQL), and is the…